Hopkins C C
Department of Medicine, Massachusetts General Hospital, Boston 02114.
Rev Infect Dis. 1991 Sep-Oct;13 Suppl 10:S869-73. doi: 10.1093/clinids/13.supplement_10.s869.
Studies published in the English-language literature on the use of prophylactic systemic antibiotics in vascular surgery, noncardiovascular thoracic surgery, mastectomy, and herniorrhaphy were reviewed. The effectiveness of antibiotic prophylaxis in preventing deep and superficial wound infections in peripheral vascular surgery appears to be well documented, especially if prophylaxis is directed against Staphylococcus aureus. In clean thoracic surgery the evidence is equivocal, and no studies have sufficient statistical power to eliminate the possibility even of a 50% reduction in incidence. In herniorrhaphy and mastectomy some evidence from a much more powerful study suggests that antibiotic prophylaxis may result in a decrease of up to 50% in wound infections, but whether these data can be generalized uncritically to all clean wounds is still a matter of debate. Accordingly, only guarded recommendations can be made regarding the use of prophylactic antibiotics in procedures associated with a very low risk of serious infection.
我们回顾了英文文献中关于在血管外科手术、非心血管胸外科手术、乳房切除术和疝修补术中使用预防性全身抗生素的研究。预防性使用抗生素在预防外周血管外科手术中深部和浅表伤口感染方面的有效性似乎已有充分记录,尤其是当预防措施针对金黄色葡萄球菌时。在清洁的胸外科手术中,证据并不明确,而且没有研究有足够的统计效力来排除感染发生率降低50%的可能性。在疝修补术和乳房切除术中,一项更具说服力的研究的一些证据表明,预防性使用抗生素可能会使伤口感染率降低多达50%,但这些数据是否能不加批判地推广到所有清洁伤口仍存在争议。因此,对于在严重感染风险极低的手术中使用预防性抗生素,只能给出谨慎的建议。